The PI3K AKT pathway in the pathogenesis of prostate cancer
The DOI matches its Crossref record.
Abstract
Despite recent advances in our understanding of the biological behavior of prostate cancer (PCa), PCa is becoming the most common malignancy in men worldwide. The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in prostate carcinogenesis. Inflammatory cytokines (CCR9, IL-6, and TLR3) regulate PI3K/AKT signaling during apoptosis of PCa cells, and PI3K/AKT signaling participates with androgen-, 1alpha,25(OH)2-vitamin D3-, and prostaglandin-associated mechanisms and is regulated by ErbB, EGFR, and the HER family during cell growth. During metastasis of PCa cells, the PI3K/AKT/NF-kappaB/BMP-2-Smad axis, PTEN/PI3K/AKT pathway, and PI3K/AKT/mTOR signaling regulates tumor cell metastasis and invasion. The present review focuses on the PI3K/AKT signal pathway and discusses the role of the PI3K/AKT signal pathway in PCa tumorigenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The PI3K/AKT signaling axis is critical in the tumorigenic process of PCa, influencing apoptosis, proliferation, metastasis, and invasion.”
From Celastrol attenuates the invasion and migration and augments the anticancer effects of olaparib in prostate cancer (2024) · cites this paper as [34]
Citations
Cites
Still being checked.
Cited by
Items 101–101 of 101
Huang, M., Chen, L., Ma, X., & Xu, H. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03542-8 · Cited by 9
“The PI3K/AKT pathway, a crucial regulator of cell growth and survival, plays a significant role in both the development and therapy of PCa [34, 35].”
Background
Metadata
- Authors
- Wen, X.
- Affiliations
- Shanghai East Hospital (CN)
- Corresponding author
- Wen, Xiaofei
- Venue
- Frontiers in Bioscience
- Publisher
- IMR Press
- Published
- 2016
- Volume
- 21
- Issue
- 5
- Pages
- 1084-1091
- ISSN
- 1093-4715 (ISSN-L)
- 1093-9946
- DOI
- 10.2741/4443
- OpenAlex
- W2328671688
- Cited by
- 283
- References
- 0
- Citations by year
- 2026: 10 · 2025: 29 · 2024: 43 · 2023: 45 · 2022: 45 · 2021: 41 · 2020: 29 · 2019: 17 · 2018: 11 · 2017: 9 · 2016: 4
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Frontiers in bioscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- prostate cancer, PI3K/Akt signaling, prostate carcinogenesis, metastasis, tumor invasion, NF-κB, PTEN, mTOR signaling, androgen signaling, vitamin D3, prostaglandins, EGFR, HER family, inflammatory cytokines, apoptosis
- MeSH terms
- Humans, Male, Neoplasm Invasiveness, Neoplasm Metastasis, Prostatic Neoplasms, Signal Transduction, Apoptosis, Cell Proliferation, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinase, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.